SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 52.00
-0.30 (-0.57%)
Aug 19, 2026, 1:30 PM CST
SCI Pharmtech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 60.12 | 107.37 | 534.68 | 294.72 | 308.78 | 55.7 |
Depreciation & Amortization | 256.02 | 252.97 | 233.79 | 145.29 | 90.61 | 63.71 |
Loss (Gain) From Sale of Assets | - | - | - | 0.58 | 1.33 | - |
Loss (Gain) From Sale of Investments | -0.05 | -1.33 | -3.62 | 1.87 | 14.07 | -2.24 |
Loss (Gain) on Equity Investments | 58.47 | 46.63 | 23.73 | 13.84 | 12.56 | 13.55 |
Stock-Based Compensation | - | - | - | 18.72 | - | - |
Other Operating Activities | -25.93 | -28.44 | 42.91 | 64.17 | -22.27 | -111.43 |
Change in Accounts Receivable | 19.71 | 41.59 | 17.86 | -133.8 | -90.59 | 254.77 |
Change in Inventory | -118.3 | -107.4 | -91.36 | -16.1 | -219.25 | 86.7 |
Change in Accounts Payable | -27.38 | 2.51 | 14.19 | -4.39 | 14.86 | -47.1 |
Change in Unearned Revenue | 29.29 | -58.81 | 56.56 | 6.59 | -9.99 | -55.53 |
Change in Other Net Operating Assets | -28.06 | -34.76 | 31.79 | -175.74 | 196.45 | 22.15 |
Operating Cash Flow | 223.89 | 220.32 | 860.52 | 215.77 | 296.57 | 280.28 |
Operating Cash Flow Growth | -78.44% | -74.40% | 298.82% | -27.25% | 5.81% | -71.15% |
Capital Expenditures | -398.32 | -610 | -946.64 | -1,029 | -1,168 | -771.03 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.07 | - |
Sale (Purchase) of Intangibles | -0.09 | -0.21 | - | - | - | -3.95 |
Investment in Securities | 17.4 | 97.54 | -62.42 | 163.27 | 156.03 | 237.42 |
Other Investing Activities | 0.8 | -0.25 | -0.3 | -0.11 | 2.4 | -2 |
Investing Cash Flow | -380.21 | -512.93 | -1,009 | -866.2 | -1,009 | -539.56 |
Short-Term Debt Issued | - | 318.5 | - | 63 | 112 | - |
Long-Term Debt Issued | - | 39.83 | 141.79 | 430.81 | 435.77 | - |
Total Debt Issued | 811.6 | 358.33 | 141.79 | 493.81 | 547.77 | - |
Short-Term Debt Repaid | - | - | -174.9 | - | - | - |
Long-Term Debt Repaid | - | -408.23 | -28.57 | -1.89 | -1.65 | -1.77 |
Total Debt Repaid | -643.79 | -408.23 | -203.47 | -1.89 | -1.65 | -1.77 |
Net Debt Issued (Repaid) | 167.81 | -49.9 | -61.68 | 491.91 | 546.12 | -1.77 |
Issuance of Common Stock | - | - | - | 957.6 | - | - |
Common Dividends Paid | -179.26 | -179.26 | -149.39 | -23.85 | - | -39.74 |
Other Financing Activities | -0.08 | 0.01 | 0.23 | - | 1 | - |
Financing Cash Flow | -11.53 | -229.15 | -210.84 | 1,426 | 547.12 | -41.52 |
Net Cash Flow | -167.86 | -521.76 | -359.68 | 775.23 | -165.4 | -300.8 |
Free Cash Flow | -174.44 | -389.68 | -86.12 | -813.59 | -871.02 | -490.75 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -13.84% | -29.00% | -5.65% | -67.56% | -96.81% | -56.79% |
Free Cash Flow Per Share | -1.44 | -3.25 | -0.72 | -7.42 | -8.10 | -4.57 |
Levered Free Cash Flow | -358.89 | -567.63 | -402.39 | -1,198 | -1,165 | -458.68 |
Unlevered Free Cash Flow | -354.19 | -564.55 | -398.93 | -1,194 | -1,165 | -458.65 |
Cash Interest Paid | 7.52 | 4.94 | 5.54 | 6.29 | 1.07 | 0.04 |
Cash Income Tax Paid | 41.9 | 23.25 | 72.31 | 4.93 | 0.11 | 115.85 |
Change in Working Capital | -124.74 | -156.88 | 29.02 | -323.43 | -108.53 | 260.99 |